Search results for PX-TA1177

Showing 1 – 10 of1products
Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade Brand Logo
ID: BAB057529368

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade, ProteoGenix, PX-TA1177

Description of Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb - Research Grade General information on Anti-CTLA4/CD152(Homo sapiens) (Tremelimumab) Monoclonal Antibody Tremelimumab is studied for the treatment of Mesothelioma, Liver Neoplasms, Liver Cancer, Liver Cell Caricinoma, and HepatoCellular Carcinoma.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.